使用分裂-Ugi反应合成可离子化脂聚合物,用于肺部输送各种大小的RNA和基因编辑
K Yu Vlasova1, A Kerr2, N D Pennock3
1Department of Pharmaceutical Sciences, College of Pharmacy at Oregon State University, Corvallis, OR, USA.
Nature communications
|April 29, 2025
概括
研究人员开发了新的电离性脂聚合物,以有效地传递mRNA. 这些纳米粒子有效地向肺细胞和免疫细胞,显示系统性基因疗法和癌症治疗的前景.
科学领域:
- 聚合物化学 聚合物化学
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 开发有效和安全的核酸输送系统对于基因疗法至关重要.
- 聚乙烯 (胺) 衍生物提供了基因传递的潜力,但经常面临毒性和内体逃逸的挑战.
- 电离性脂质和聚合物是制定纳米颗粒的关键组成部分,用于有效的核酸输送.
研究的目的:
- 为了合成功能性电离性脂聚合物的图书馆,使用分裂-Ugi反应用于基因传递应用.
- 建立结构-活性关系,以提高内体体逃逸和转染效率.
- 在体内开发和评估脂质聚合物-脂质混合纳米颗粒,用于将mRNA输送到肺和免疫细胞.
主要方法:
- 通过多元组分分裂-Ugi反应合成化聚乙烯 (氨酸) 衍生物.
- 将155种聚合物制成多重复体,以研究结构-活性关系.
- 开发用于mRNA输送的脂聚合物-脂质混合纳米粒子.
- 在小鼠模型中对纳米粒子疗效和毒性的体内评估.
主要成果:
- 创建了一个功能性电离性脂聚合物的库,其中155种聚合物被配制成多重复合物.
- 脂聚合物结构显示出高效的内分体逃逸和转染.
- 混合纳米颗粒有效地将mRNA传递到肺内皮和免疫细胞 (包括T细胞) 中,具有低毒性.
- 与体内JetPEI®相比,纳米颗粒显示出优异的肺mRNA输送.
- 对IL-12 (癌症),CFTR (囊性纤维化) 和CRISPR-Cas9 (基因编辑) 进行治疗的mRNA传递被证明是有效的.
结论:
- 开发的脂聚合物平台可为各种治疗应用提供高效和有针对性的mRNA输送.
- 该研究确定了优化基因传递纳米粒子的关键结构-活性关系.
- 该平台显示了系统性基因治疗的巨大潜力,包括癌症治疗和体内基因编辑.
更多相关视频
10:02Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
2.1K
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10.6K
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.7K
RNA Editing
8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
